Odimont AB: A Combination Therapy for Chronic Respiratory Problems

Odimont AB is a tablet containing two active ingredients, Acebrophylline (200mg) and Montelukast (10mg), used to manage chronic respiratory conditions like asthma.

Acebrophylline, a well-established bronchodilator, relaxes the muscles in the airways, improving airflow and alleviating symptoms like shortness of breath.
Montelukast, a potent leukotriene receptor antagonist, inhibits inflammatory mediators that contribute to airway constriction and swelling. This helps reduce the frequency and severity of asthma attacks.

Odimont AB provides dual therapy for effective symptom management:

* Reduces bronchospasm: Opening up airways for easier breathing.
* Suppresses inflammation: Alleviating inflammation in the lungs and airways.

This combination offers a comprehensive approach to tackling chronic respiratory issues, improving quality of life for patients.

Please consult with a healthcare professional before taking Odimont AB.